Trials / Recruiting
RecruitingNCT06222164
The Use of Residual De-identified Specimens and/or Samples From Patients for Clinical Research
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,000 (estimated)
- Sponsor
- Invivoscribe, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Acquire residual human specimens and/or samples from patient samples which were sent for testing at LabPMM, LLC for Clinical Research
Detailed description
Residual specimen/sample collection study where peripheral blood (PB), bone marrow (BM), genomic (gDNA), and/or formalin-fixed paraffin-embedded tissue (FFPE) specimens/samples are obtained from patient samples sent to LabPMM, LLC for clinical testing. Samples may be used for Clinical Research at LabPMM, LLC or at partner institutions
Conditions
Timeline
- Start date
- 2024-03-30
- Primary completion
- 2027-03-30
- Completion
- 2027-06-30
- First posted
- 2024-01-24
- Last updated
- 2025-05-04
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06222164. Inclusion in this directory is not an endorsement.